Company Description
Genzyme makes big money off small-time diseases. The company's product portfolio focuses on rare genetic disorders as well as organ transplant,...
Key Genzyme Financials
| Company Type | Public - NASDAQ (GS): GENZ Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $3,813.5 |
| 2007 Employees | 10,000 |
More Genzyme Financials (11 pages)
Latest Genzyme Jobs jobs by Indeed
Rankings
- S&P 500
- #477 in FT Global 500
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Genzyme's competition across multiple industries
Top Genzyme Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Genzyme Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, President, and CEO | Henri A. Termeer | Network | E-mail |
| EVP Finance, CFO, and Chief Accounting Officer | Michael S. Wyzga | Network | E-mail |
| SVP Corporate Development | Richard H. Douglas | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current Genzyme News
- BioWorld Today July 18, 2008 [BioWorld Today] (18 Jul 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (17 Jul 2008 23:00:00 EDT)
- Briefing.com: Hourly In Play (R) - 22:00 ET [Briefing.com] (17 Jul 2008 22:01:00 EDT)
Latest Genzyme Video
-
Genzyme CEO on Earnings (3:31)
10/24/07 3:31ET - Genzyme CEO Henri Termeer discusses his company's latest earnings results with CNBC's Maria Bartiromo.







